Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
Pluristem Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 8, 2021
Pluristem Therapeutics reported fiscal year 2020 executive compensation information on April 8, 2021.
In 2020, three executives at Pluristem Therapeutics received on average a compensation package of $353K, a 44% decrease compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chairman, received $501K in total, which decreased by 54% compared to 2019. 88% of Aberman's compensation, or $440K, was in salary. Aberman also received $62K in other compensation.
Yaky Yanay, Chief Executive Officer, received a compensation package of $350K, which decreased by 60% compared to previous year. 92% of the compensation package, or $321K, was in salary.
Chen Franco-Yehuda, Chief Financial Officer, earned $208K in 2020, a 1% increase compared to previous year.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on April 8, 2021.